en · de · es
selank-notes.peptides3081.com › News › Mechanism And Evidence Base — Explained

Mechanism And Evidence Base — Explained

By Editorial Desk · published 2026-07-13 · last reviewed 2026-08-01 · News

Peptidase stability comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.

Updated 2026-08-01. Numbers and descriptions here follow the published literature rather than marketing material.

Mechanism and Evidence Base

Clinical evidence comes mainly from small studies conducted in Russia, several of which were open-label or lacked robust blinding. Reported outcomes include lower anxiety scores, changes in attention measures, and effects on asthenic states following illness. Sample sizes are typically in the tens of participants, and independent replication outside the region is scarce. Reviews published in English generally note the limited methodological quality of the underlying trials. Whether the compound produces clinically meaningful effects under rigorous conditions remains unresolved.

Proposed mechanisms center on modulation of the GABA system, but no single molecular target has been confirmed. Rodent studies report changes in GABA-A receptor expression and in the turnover of serotonin, dopamine, and norepinephrine in several brain regions. Increases in brain-derived neurotrophic factor and its receptor have also been described after repeated administration. These findings come largely from animal models, and the degree to which they describe human neurochemistry remains an open question. The mechanism is best characterized as multi-system and not fully resolved.

Pharmacokinetic data are limited. Like most short peptides, Selank is vulnerable to plasma and tissue peptidases, and its measured half-life in circulation is short, on a minutes scale. The Pro-Gly-Pro tail slows this degradation but does not eliminate it. Intranasal administration is the route described in most reports, with absorption through the nasal mucosa and a hypothesized path into the central nervous system that avoids the blood-brain barrier. Direct measurements of human brain exposure are unavailable, so distribution claims rest on inference from animal work.

Selank Origin and Chemical Identity

Regulatory status differs sharply by region. Selank holds a Russian marketing authorization, where it is supplied mainly as nasal drops, while authorities elsewhere have not approved it for medical use. Material sold internationally is therefore usually labeled as a research chemical rather than a medicine. Peer-reviewed publications come predominantly from Russian laboratories, and sample sizes are generally small. Whether the compound produces comparable effects under independent, well-controlled replication remains an open question that the broader literature has not settled.

Selank is a synthetic heptapeptide developed in Russia as a structural analogue of tuftsin, a naturally occurring immunomodulatory tetrapeptide. Its sequence, Thr-Lys-Pro-Arg-Pro-Gly-Pro, keeps the tuftsin core at the N-terminus and appends a Pro-Gly-Pro tail. Researchers at the Institute of Molecular Genetics in Moscow synthesized the compound during the 1990s while searching for peptides with combined anxiolytic and immunomodulatory activity. The added tail was intended to resist enzymatic cleavage and prolong the molecule's presence in circulation.

Selank at a glance

PropertyValueNotes
Route studiedIntranasalPredominant route in published reports
Circulation stabilityShort, minutes scalePeptidases cleave it; the tail slows the process
Analytical methodRP-HPLC with mass spectrometryUsed for identity and purity assessment
Reported outcome domainsAnxiety and cognitive measuresDerived from small, mostly regional trials
Regulatory statusMarketed in RussiaAvailability outside that market is limited

Selank Background and Peptide Chemistry

Most published work on selank originates from a small number of research groups in the Russian Federation. A large share of that record appears in Russian-language journals, which limits access for readers who rely on English-indexed databases. Independent replication by laboratories outside the original research network is sparse in publicly available sources. This concentration of origin and language is a frequently noted feature when the compound is summarized in broader reviews of synthetic peptides.

Reported pharmacological effects center on reduced anxiety-like behavior in animal models and on measures of memory and learning. Proposed contributing mechanisms include modulation of GABAergic signaling, shifts in monoamine turnover, and changes in the activity of enzymes that degrade neuropeptides. Effects on the expression of genes linked to neuroplasticity have also been described. No single molecular target is widely accepted, and whether the behavioral findings arise from one pathway or several remains an open question.

Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It was designed as a stabilized analogue of tuftsin, a naturally occurring tetrapeptide fragment derived from the immunoglobulin heavy chain. The additional Pro-Gly-Pro segment at the carboxyl terminus is intended to slow enzymatic cleavage. The compound is usually described in the literature as a synthetic peptide with anxiolytic and cognitive-related activity, a label that reflects a research context rather than an approved therapeutic category.

Related pages on this site

Origins and Proposed Mechanisms

Published clinical evidence is limited. Most controlled trials were conducted in Russia, enrolled modest numbers of participants, and appeared in Russian-language journals, which restricts independent verification. Reported outcomes include lower anxiety scores, improved attention and memory measures, and changes in fatigue ratings. Reviews written in English note methodological limitations such as small samples and inconsistent endpoints. Whether the compound produces clinically meaningful benefit relative to established anxiolytics is therefore an open question rather than an established finding.

Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It was designed at the Institute of Molecular Genetics of the Russian Academy of Sciences as a structural analogue of tuftsin, a naturally occurring tetrapeptide fragment of the immunoglobulin heavy chain. The added Pro-Gly-Pro tail was intended to slow enzymatic degradation and extend biological activity. In Russia it is registered as an anxiolytic nasal preparation, while regulators elsewhere have not approved it for clinical use.

Notes from published material

Adoptive immunity acts in a host after their immunological components are withdrawn, their immunological activity is modified extracorporeally, and then reinfused into the same host. This process in its former part is analogous to adoption: a child is once adopted out from their home, grown up, and then returned to their home of birth. Transferred immunological components include immune cells such as T lymphocytes or tumour-infiltrating lymphocytes, NK cells, macrophages, or B cells. There seems to be some variation in usage of this term.

After college, Guillaume joined the Karamu Players in Cleveland and performed in musical comedies and opera. He toured the world in 1959 as a cast member of the Broadway musical Free and Easy. He made his Broadway debut in Kwamina in 1961. His other stage appearances included Golden Boy (with Sammy Davis Jr.), Tambourines to Glory, Guys and Dolls, for which he received a Tony Award nomination, Jacques Brel is Alive and Well and Living in Paris, and Purlie. His additional roles included Katherine Dunham's Bambouche and in Fly The Blackbird. In 1964, Guillaume portrayed Sportin' Life in a revival of Porgy and Bess at New York City Center. Guillaume was a member of the Robert De Cormier Singers, performing in concerts and on television. He recorded an LP album, Columbia CS9033, titled Just Arrived, as a member of The Pilgrims, a folk trio, with Angeline Butler and Millard Williams. Columbia records producer Tom Wilson had set out to create the Pilgrims as an answer to the popular folk trio Peter, Paul and Mary. By early 1964, the Pilgrims had recorded a handful of songs and Wilson was looking for the right song for the group's debut single when a then-unknown singer/songwriter named Paul Simon arrived for a meeting with Wilson and eventually pitched his new composition, "The Sound of Silence". Wilson liked the song and had Simon record a demo for the group, but when Simon and his friend, Art Garfunkel, sang the song for Wilson in person, he signed them to a record contract instead of using it for The Pilgrims.

=== July === 1 July – The ESA space telescope Euclid is launched, beginning a six-year mission to study dark energy and dark matter. 3 July – Researchers demonstrate encoding and storing data – small images – as DNA without new DNA synthesis by recording light exposure into bacterial DNA via optogenetic circuits. The 'biological camera' extends chemical and electrical interface techniques. 5 July Harvard astronomer Avi Loeb reports the possibility of a Galileo project expedition having found first interstellar material. A first evolution experiment of synthetic 'minimal cells' – JCVI-syn3B bacterial cells whose genomes were trimmed to 493 essential genes and are the smallest of any known free-living organism – shows they survive and mutate vitally with their >50% decrease in fitness to JCVI-syn1 being regained after ~2,000 generations under accelerated evolution. 6 July – A study indicates release of methane from Arctic glacial retreat will result in Arctic emissions much higher than expected.

Concerns regarding the sustainability of Chinese-financed projects, environmental impacts, and the lack of transparency in their investments call for a careful assessment of these collaborations. Iranian President Mahmoud Ahmadinejad met with Mahama in 2013 to hold discussions on strengthening the Non-Aligned Movement and also co–chair a bilateral meeting between Ghana and Iran at the Ghanaian presidential palace Flagstaff House. The Sustainable Development Goals (SDG) were integrated into Ghana's development agenda and the budget. According to reports, the SDGs were implemented through a decentralized planning approach. This allows for stakeholders' participation, such as in UN agencies, traditional leaders, civil society organizations, academia, and others. The 17 SDGs are a global call to action to end poverty among others, and the UN and its partners in the country are working towards achieving them. According to the President Nana Akufo-Addo, Ghana was "the first Sub-Saharan African country to achieve the goal of halving poverty, as contained in Goal 1 of the Millennium Development Goals".

In pharmacology and pharmaceutics, a prototype drug is an individual drug that represents a drug class – group of medications having similar chemical structures, mechanism of action and mode of action. Prototypes are the most important, and typically the first developed drugs within the class, and are used as a reference to which all other drugs are compared.

Sources: en.wikipedia.org

Background from the literature

=== Deaths === Combined consumption of U-47700 with fentanyl and flubromazepam caused one fatality each in Belgium and Germany, respectively. One death was reported in Ireland and another one in Italy. 17 opioid overdoses and several deaths in the United States had initially been associated with U-47700 in April 2016. As of September 2016 at least 15 fatalities were confirmed. By December 2017, at least 46 fatalities had been associated with the use of U-47700. U-47700 was found in combination with fentanyl during the autopsy of the American artist Prince in 2016.

=== IARW === The International Association of Refrigerated Warehouses (IARW) was founded in 1891. It was created when a group of conventional (non-refrigerated) warehouse owners began sharing knowledge about storing perishable food. As perishable food storage is complex, this organization soon became known industry-wide for their expertise about temperature controlled storage facilities. IARW's goals and activities broadened over the years. In addition to collecting information and encouraging the exchange of ideas, the association promoted efficiency in distribution, aids members in adopting new technology, advises legislators on behalf of the food industry, assists members in complying with U.S. and international regulations, and participates in alliances with international organizations to build an efficient world food logistics community. All active members of IARW are also members and beneficiaries of the work of The World Food Logistics Organization (WFLO).

According to the Australian Forest and Wood Products Research and Development Corporation (FWPRDC), green sawn hardwood, which is sold at about $350 per cubic metre or less, increases in value to $2,000 per cubic metre or more with drying and processing. However, currently used conventional drying processes often result in significant quality problems from cracks, both externally and internally, reducing the value of the product. For example, in Queensland (Anon, 1997), on the assumption that 10% of the dried softwood is devalued by $200 per cubic metre because of drying defects, saw millers are losing about $5 million a year. In Australia, the loss could be $40 million a year for softwood and an equal or higher amount for hardwood. Thus, proper drying under controlled conditions prior to use is of great importance in timber use, in countries where climatic conditions vary considerably at different times of the year. Drying, if carried out promptly after felling of trees, also protects timber against primary decay, fungal stain and attack by certain kinds of insects. Organisms, which cause decay and stain, generally cannot thrive in timber with a moisture content below 20%. Several, though not all, insect pests can live only in green timber. In addition to the above advantages of drying timber, the following points are also significant:

This policy was abolished in 2000 in favour of a scheme generally known as Pet Passports, under which animals can avoid quarantine if they have documentation showing they are up to date with their appropriate vaccinations. In the past, European countries implemented quarantine measures to curb the Bubonic Plague and Cholera. In the British Isles, for example, the Quarantine Act 1710 (9 Ann. c. 2) established maritime quarantine policies in an era in which strict border control measures as a whole were yet to become mainstream. The first act was called for due to fears that the plague might be imported from Poland and the Baltic states. A second act of Parliament, the Quarantine Act 1721 (8 Geo. 1. c. 10), was due to the prevalence of the plague at Marseille and other places in Provence, France. It was renewed in 1733 after a new outbreak in continental Europe, and again in 1743, due to an epidemic in Messina. A rigorous quarantine clause was introduced into the Levant Act 1752, an act regulating trade with the Levant, and various arbitrary orders were issued during the next twenty years to meet the supposed danger of infection from the Baltic states. Although no plague cases ever came to England during that period, the restrictions on traffic became more stringent, and a very strict Quarantine and Customs Act 1788 (28 Geo. 3. c. 34) was passed, with provisions affecting cargoes in particular.

Sources: en.wikipedia.org

Frequently asked questions

What mechanisms are proposed for Selank?

Reports describe effects on GABA-A receptor expression, monoamine turnover, and neurotrophic factor levels. These are proposed mechanisms drawn mainly from animal models. No single molecular target has been established.

How is Selank typically given in studies?

Intranasal delivery is the route described in most published work. It is used because the peptide is degraded quickly once it reaches circulation. Direct evidence of brain penetration in humans is lacking.

How strong is the clinical evidence?

Most trials are small, regionally concentrated, and often lack rigorous blinding or placebo control. Independent replication is limited. Reviews in English generally rate the evidence as preliminary.

What is Selank?

Selank is a synthetic seven-amino-acid peptide modeled on tuftsin, a fragment of the immunoglobulin G heavy chain. It was designed in Russia to combine anxiolytic and immunomodulatory properties in one molecule.

Network